or Try an Advanced Search...

    Technical Analysis for SXTP - 60 Degrees Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.71 -10.64% -0.09
    SXTP closed down 10.64 percent on Friday, September 22, 2023, on 9 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical SXTP trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    New 52 Week Closing Low Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for SXTP ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 10% 3 days ago
    Down 5% 3 days ago
    60 Minute Opening Range Breakdown 3 days ago
    Down 3% 3 days ago
    Rose Above Lower Bollinger Band 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SXTP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Infectious Diseases Infection Malaria Covid 19 Dengue Epidemiology Tropical Diseases Vaccine Preventable Diseases Candidiasis Dengue Fever Tick Borne Diseases Treatment Of Infectious Diseases

    Is SXTP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 19 Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
    Sep 18 60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
    Sep 6 60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference
    Sep 1 Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
    Aug 30 60 Degrees Pharmaceuticals Study Results Published by New Microbes and New Infections Demonstrate Tafenoquine Exhibits Broad Spectrum Antifungal Activity
    Aug 22 60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
    Aug 15 60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB Study of Tafenoquine for Treatment of COVID-19, on ClinicalTrials.gov
    Jul 31 60 Degrees Pharmaceuticals Awarded Canadian Patent Covering Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects
    Jul 21 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
    Jul 19 Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    See more SXTP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.65
    52 Week Low 0.71
    Average Volume 566,034
    200-Day Moving Average 0.00
    50-Day Moving Average 1.71
    20-Day Moving Average 1.19
    10-Day Moving Average 1.03
    Average True Range 0.16
    RSI (14) 20.00
    ADX 14.41
    +DI 18.25
    -DI 37.39
    Chandelier Exit (Long, 3 ATRs) 1.07
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.64
    Lower Bollinger Band 0.74
    Percent B (%b) -0.03
    BandWidth 75.04
    MACD Line -0.28
    MACD Signal Line -0.27
    MACD Histogram -0.0072
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.85
    Resistance 3 (R3) 0.86 0.83 0.83
    Resistance 2 (R2) 0.83 0.80 0.82 0.82
    Resistance 1 (R1) 0.77 0.78 0.76 0.76 0.81
    Pivot Point 0.74 0.74 0.73 0.73 0.74
    Support 1 (S1) 0.68 0.71 0.67 0.67 0.62
    Support 2 (S2) 0.65 0.69 0.64 0.61
    Support 3 (S3) 0.59 0.65 0.60
    Support 4 (S4) 0.58